Zurich, Switzerland

Peter Stregt

This inventor holds 1 USPTO granted patent. Top assignee: Universität Zürich. Active years: 2004.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter Stregt. Retrieved from https://idiyas.com/inventor/peter-stregt

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 25(Granted Patents)


Company Filing History:


Years Active: 2004

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Peter Stregt

Introduction

Peter Stregt is a notable inventor based in Zurich, Switzerland. He has made significant contributions to the field of immunology, particularly in the detection of prions. His work is crucial for advancing therapeutic and preventive treatments for prion diseases in both humans and animals.

Latest Patents

Peter Stregt holds a patent for the "Immunological detection of prions." This invention involves the use of monoclonal antibodies that are effective in sensitive and specific immunological assays for identifying prions in various tissues and body fluids. The production of these monoclonal antibodies is achieved through the immunization of PrP mice using a new recombinant fragment of PrP. The antibodies developed can be utilized for therapeutic and preventive treatments for those suffering from prion diseases.

Career Highlights

Peter Stregt is affiliated with the University of Zurich, where he continues to engage in groundbreaking research. His work has garnered attention for its potential impact on public health and veterinary medicine.

Collaborations

Some of his notable coworkers include Carsten Korth and Markus Moser, who have contributed to his research endeavors.

Conclusion

Peter Stregt's innovative work in the detection of prions exemplifies the importance of research in immunology. His contributions are paving the way for advancements in the treatment of prion diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…